With the business potentially at an important milestone, we thought we'd take a closer look at LifeStance Health Group, Inc.'s (NASDAQ:LFST) future prospects. LifeStance Health Group, Inc., through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The US$2.6b market-cap company announced a latest loss of US$57m on 31 December 2024 for its most recent financial year result. Many investors are wondering about the rate at which LifeStance Health Group will turn a profit, with the big question being “when will the company breakeven?” Below we will provide a high-level summary of the industry analysts’ expectations for the company.
This technology could replace computers: discover the 20 stocks are working to make quantum computing a reality.
Consensus from 6 of the American Healthcare analysts is that LifeStance Health Group is on the verge of breakeven. They anticipate the company to incur a final loss in 2025, before generating positive profits of US$4.8m in 2026. Therefore, the company is expected to breakeven just over a year from now. What rate will the company have to grow year-on-year in order to breakeven on this date? Using a line of best fit, we calculated an average annual growth rate of 99%, which is extremely buoyant. If this rate turns out to be too aggressive, the company may become profitable much later than analysts predict.
We're not going to go through company-specific developments for LifeStance Health Group given that this is a high-level summary, but, bear in mind that generally a high forecast growth rate is not unusual for a company that is currently undergoing an investment period.
See our latest analysis for LifeStance Health Group
Before we wrap up, there’s one aspect worth mentioning. The company has managed its capital judiciously, with debt making up 20% of equity. This means that it has predominantly funded its operations from equity capital, and its low debt obligation reduces the risk around investing in the loss-making company.
There are key fundamentals of LifeStance Health Group which are not covered in this article, but we must stress again that this is merely a basic overview. For a more comprehensive look at LifeStance Health Group, take a look at LifeStance Health Group's company page on Simply Wall St. We've also put together a list of relevant aspects you should further examine:
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。